The Institute of Intellectual Property Research & Development (IIPRD) is organising a three-day international symposium on 'Strategies for managing pharma, biotech and chemical patent portfolio' from September 16 to 18, 2012, in Mumbai.

The symposium will focus on patent life-cycle management, strategies for generics as innovators, biosimilar legislation, FDA's current position and patent disputes, latest pharma prosecution practices and ANDA litigation. It is organised with the support of Sughrue Mion, PLLC, USA & Hoffmann Eitle, Europe & Khurana & Khurana, Advocates and IP Attorneys, India.

This seminar will feature presentation of patent issues such as identification of potential inventions, types of claims allowed in each geography and their relevance to the broadness of claims, preparation of set of claims, prosecution and examination practices, drafting of responses of office actions, ANDA litigation and issues related to biosimilars legislation and understanding the FDA's current position on the implementation of a biosimilar pathway.

This symposium is useful for research and development scientists, IP managers, patent agents and attorneys in the field of practice, patent litigators and managers in generic drug companies, professionals in legal domain related to pharma, biotech and chemicals.

Tarun Khurana, partners with Khurana & Khurana said that this workshop will provide ample opportunities to get first-hand information including recent Judgement on various issues and to discuss personal patent problems on a confidential basis from the experts in the fields. This will provide them to interact with patent experts from varied backgrounds and having enormous expertise and different perception.

Prominent speakers of the seminar include Dr Stephan Disser, Dr Leonard Werner-Jones, Tarun Khurana, Chid Iyer, Azy S Kokabi, Renita S Rathinam, Michael R Dzwonczyk and Dr William Simmonsare.